Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Alba

11 clinical trials in Alba, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Alba at a glance
11
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

11 trials in Alba

Open in trial search

Study Comparing Docetaxel and Androgen Receptor-Targeted Agents (Abiraterone or Enzalutamide) for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia

Prostate cancer

Recruiting

Study of Apalutamide and Radiation Therapy for Patients with Low Burden Metastatic Hormone Sensitive Prostate Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Fondazione Radioterapia Oncologica Onlus

Osimertinib and drug combination in metastatic non‑small cell lung cancer with targetable genomic driver alterations

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Universita' Degli Studi Di Torino

Comparison of nivolumab drug combination versus immunotherapy‑TKI sequence in patients with metastatic renal cell carcinoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Fondazione IRCCS Istituto Nazionale Dei Tumori

Prostate cancer

Not yet recruiting

Study on Prostate Cancer: Comparing Stereotactic Body Radiation Therapy Alone or with Triptorelin and Bicalutamide for Patients with Acinar Cell Prostatic Carcinoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bicalutamide
  • Sponsor:Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

Study on Niraparib for Patients with Advanced Urothelial Cancer After Initial Platinum Chemotherapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Niraparib Tosilate Monohydrate
  • Sponsor:Universita' Degli Studi Di Torino

Prostate cancer

Not yet recruiting

Study on Docetaxel and Carboplatin-Docetaxel Combination for Prostate Cancer Patients Progressing After Olaparib Treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Azienda Provinciale Per I Servizi Sanitari

Ovarian cancer

Not recruiting

Phase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:INCB123667
  • Sponsor:Incyte Corp.

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Cervix carcinoma

Not recruiting

Study on the Effectiveness of HPV 9-Valent Vaccine in Women Undergoing LEEP for High-Grade Cervical Lesions or Early Cervical Cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Water For Injection
  • Sponsor:Azienda Unita Sanitaria Locale Toscana Nord Ovest

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Alba

What the registry says about research in the country

01 Urological Oncology

Research focusing on innovative treatments for urothelial cancer and advanced therapeutic approaches for patients following platinum-based chemotherapy. Clinical studies are evaluating maintenance therapies to extend disease-free progression.

  • Urothelial Cancer Treatment
  • Maintenance Therapy Studies
  • Post-Chemotherapy Care

Investigations aim to improve long-term outcomes for patients with locally advanced or metastatic disease.

02 Prostate Cancer Research

Multiple studies exploring treatment options for metastatic prostate cancer, including comparisons between traditional chemotherapy and newer hormone-based therapies. Research includes innovative approaches combining radiation therapy with systemic treatments.

  • Hormone-Sensitive Disease Management
  • Advanced Treatment Combinations
  • Targeted Therapies

Focus on developing personalized treatment strategies for different stages of prostate cancer.

03 Women's Health Oncology

Groundbreaking research in cervical cancer prevention and treatment, investigating the effectiveness of pre-surgical vaccination protocols and management of high-grade cervical neoplasia.

  • HPV Vaccination Studies
  • Surgical Intervention Outcomes
  • Disease Recurrence Prevention

Studies aim to reduce post-surgical disease recurrence and improve treatment outcomes.

04 Colorectal Cancer Studies

Advanced research in metastatic colorectal cancer treatment, comparing different therapeutic combinations and investigating the role of targeted biologics in first-line therapy.

  • Targeted Therapy Optimization
  • Biomarker-Driven Treatment
  • Combination Therapy Assessment

Focus on personalizing treatment based on molecular profiling and liquid biopsy results.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.